Studying side effects of lymph node removal in lung cancer surgery
Part of Cancer, Lungs & breathing clinical trials.
This trial looks at complications from removing lymph nodes during surgery for non-small cell lung cancer. It may help doctors understand how to make surgery safer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old.
- You have non-small cell lung cancer at an early to advanced stage (stage IA to IIIB).
- Your planned surgery will remove a section or all of a lung and include removal of lymph nodes around the windpipe.
- You agree to take part in the study and sign a consent form.
- You cannot have small cell lung cancer, benign tumors, or tumors that started elsewhere.
- You cannot have a minor wedge surgery that leaves lymph nodes in place.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares removing fewer lymph nodes during surgery for early-stage non-small cell lung cancer. It is for people with a small tumor (2 cm or less) that has both solid and ground-glass parts.
This trial compares two ways of removing lymph nodes during lung cancer surgery after you've had pre-surgery immunotherapy and chemotherapy. It aims to see if taking only a few key lymph nodes (instead of all of them) is just as effective and leads to fewer side effects.
This study looks at whether removing lymph nodes from the opposite side of the chest during surgery can help people with advanced lung cancer that has spread to the lymph nodes in the middle of the chest. It may offer a more thorough treatment for patients who are healthy enough for surgery.
This study looks at certain lymph nodes removed during surgery for non-small cell lung cancer (NSCLC) that has grown into the covering of the lung. The goal is to better understand lymph node involvement and help guide future treatment decisions.
This study tests a new way to decide which lymph nodes to remove during lung cancer surgery. The goal is to make surgery more precise and reduce side effects while still effectively removing cancer.
This trial compares two ways of doing lung cancer surgery for early-stage tumors in the left lung. Some participants will have more lymph nodes removed (station 4L) and others will not, to see if the extra removal helps prevent the cancer from coming back.
Hear when a new Lymph Node Dissection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.